Lothar Stitz

Title: Lothar Stitz: Innovator in Vaccine Development

Introduction

Lothar Stitz is a prominent inventor based in Rottenburg, Germany. He has made significant contributions to the field of vaccine development, holding a total of 11 patents. His work focuses on innovative solutions for immunization, particularly in vulnerable populations such as newborns and infants.

Latest Patents

Among his latest patents is a groundbreaking invention related to vaccination in newborns and infants. This invention involves vaccines that comprise at least one mRNA encoding an antigen for treating diseases in very young children, specifically those under the age of two. The treatment aims to elicit an immune response in these infants, enhancing their protection against various diseases. Another notable patent is for a rabies vaccine, which includes an mRNA sequence encoding antigenic peptides or proteins of the rabies virus. This invention also encompasses a composition of multiple mRNA sequences for the preparation of a pharmaceutical composition, particularly a vaccine for rabies virus infections.

Career Highlights

Lothar Stitz has worked with notable companies in the biotechnology sector, including CureVac AG and CureVac SE. His experience in these organizations has allowed him to contribute to the advancement of mRNA technology in vaccine development.

Collaborations

Throughout his career, Lothar has collaborated with esteemed colleagues such as Thomas Kramps and Margit Schnee. These partnerships have further enriched his research and innovation efforts in the field of immunology.

Conclusion

Lothar Stitz is a key figure in the development of innovative vaccines, particularly for young children. His patents reflect a commitment to improving public health through advanced immunization strategies. His contributions continue to shape the future of vaccine technology.